Moneycontrol
Get App
Last Updated : Jul 12, 2019 04:50 PM IST | Source: Moneycontrol.com

Dr. Reddy’s Laboratories Q1 PAT seen up 13.6% YoY to Rs. 540.8 cr: Prabhudas Lilladher

Net Sales are expected to increase by 2.2 percent Y-o-Y (down 5.2 percent Q-o-Q) to Rs. 3,820.3 crore, according to Prabhudas Lilladher.

Moneycontrol News @moneycontrolcom
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Prabhudas Lilladher has come out with its first quarter (April-June’ 19) earnings estimates for the Pharma sector. The brokerage house expects Dr. Reddy’s Laboratories to report net profit at Rs. 540.8 crore up 13.6% year-on-year (up 18.8% quarter-on-quarter).


Net Sales are expected to increase by 2.2 percent Y-o-Y (down 5.2 percent Q-o-Q) to Rs. 3,820.3 crore, according to Prabhudas Lilladher.


Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to rise by 6.7 percent Y-o-Y (up 0.2 percent Q-o-Q) to Rs. 820.6 crore.


Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

First Published on Jul 12, 2019 04:50 pm
Loading...
Sections
Follow us on
Available On
PCI DSS Compliant